Clinical Trials Logo

Urinary Incontinence clinical trials

View clinical trials related to Urinary Incontinence.

Filter by:

NCT ID: NCT04087642 Recruiting - Clinical trials for Pelvic Organ Prolapse

CREDE Study: Intraoperative Crede Manoeuver Compared to Preoperative Prolapse Reduction Stress Test to Predict Postoperative de Novo Stress Urinary Incontinence (PONSUI) at the Time of Pelvic Organ Prolapse (POP) Surgery

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

The CREDE pilot randomized study will compare the intraoperative Crede manoeuver (M1) to preoperative prolapse (POP) reduction cough stress test (M2) for the prediction and prevention of PONSUI. The rates of PONSUI and its effect on patient reported outcomes and quality of life will be determined among women with positive or negative tests, and those with and without concomitant anti-incontinence procedure performed. This information will help inform larger studies on the topic.

NCT ID: NCT04078373 Recruiting - Clinical trials for Urinary Incontinence

Urinary Disorders in Subacute Patients After Stroke

UIMK
Start date: June 1, 2019
Phase:
Study type: Observational

This observational study will address urinary disorders in subacute stroke patients. Patients without and with urinary disorders will be compared, and treatment outcome will be assessed among the latter.

NCT ID: NCT04074044 Recruiting - Clinical trials for Urinary Incontinence

Evaluation of a New Bladder Health Mobile Application in Pregnancy

BHmApp
Start date: April 20, 2023
Phase: N/A
Study type: Interventional

Millions of women experience involuntary loss of urine called urinary incontinence (UI). UI can be slightly bothersome or totally debilitating. Women experience UI twice as often as men. Urinary incontinence can also be a persistent condition caused by underlying physical problems or changes, including pregnancy and childbirth. UI symptom severity progress dynamically and are also sustained over time. High quality evidence shows that pelvic floor muscle training (PFMT) during pregnancy effectively reduces the risk of UI during pregnancy and the postpartum period. There is a critical need for a low cost and easily accessible program to prevent UI in pregnancy and postpartum that can reach a large number of women. A mobile health application that teaches UI preventive program during pregnancy has the potential of being a cost effective tool to reach a large number of pregnant women. The Bladder Health Mobile Application (BHmApp) will teach pregnant women new habits and exercises that will keep their bladder healthy during pregnancy and decrease the risk of UI during this period of a woman's life that is considered high risk for developing UI. In this pilot study, it is proposed to evaluate the understand and effectively use the BHmApp, and the feasibility of using the BHmApp during pregnancy.

NCT ID: NCT04059133 Recruiting - Overactive Bladder Clinical Trials

The Effect of Low Intensity Extracorporeal Low Energy Shock Wave Therapy on Stress Urinary Incontinence and Overactivity Bladder

Start date: February 27, 2018
Phase: N/A
Study type: Interventional

The hypothesis of the present study is low intensity extracorporeal low energy shock wave therapy (LiESWT) can decrease inflammatory disorders, increase pelvic floor blood supply, enhanced bladder stem cell activation, Using LiESWT can decrease bladder overactivity, eliminate urinary incontinence and improve stress urinary incontinence (SUI) and overactive bladder (OAB) symptoms. Therefore improve quality of life and improve social activity.

NCT ID: NCT04031014 Recruiting - Overactive Bladder Clinical Trials

High Intensity Focused Electromagnetic Field Device for Urinary Incontinence

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

High intensity focused electromagnetic (HIFEM) technology induces deep pelvic floor muscle contractions designed to deliver the equivalent of 11,200 Kegel exercise over 28 minutes, with the intention of increasing neuromuscular tone of the pelvic floor. This study will have looking at treatment of the two of the most common pelvic floor disorders: stress or stress predominant urinary incontinence and urge or urge predominant urinary incontinence.

NCT ID: NCT04010162 Recruiting - Clinical trials for Urinary Incontinence

Mesh Debate Awareness Among Non-urogynecologists. A Practical Survey Study.

Mesh_Survey
Start date: March 1, 2019
Phase:
Study type: Observational

This study evaluates the awareness of mesh discussions in urogynecology among non-urogynecologists. A web-based questionnaire will be sent to four groups. Group-1 is King's College Hospital doctors. Group-2 is Uludag University Hospital doctors. Group-3 is doctors from the United States, and Group-4 is doctors from all over the world.

NCT ID: NCT04008108 Recruiting - Clinical trials for Urinary Incontinence

Variation of Physical Activity, Measured by the Number of Steps Per Day, After Artificial Urinary Sphincter Implantation

AP-SU
Start date: July 29, 2019
Phase: N/A
Study type: Interventional

The management of urinary incontinence seems to improve daily activities and the practice of physical activity, according to the literature. Unfortunately, all of these studies are based on self-questionnaires with the disadvantages of self-evaluation, more subjective. For several years activity sensors have been used in the medical field (rheumatology, cardiology, diabetology, etc.). They allowed the evaluation of physical activity in real life situations, whether to evaluate the degree of severity of a pathology or the impact of a new treatment on the resumption of activities. Activity sensors are devices that transform body motion into digital measurements. They provide detailed information on the frequency, duration, intensity and type of movement to determine, for example, the number of steps taken, the distance traveled, calories burned and the quality of sleep. It is hypothesized that urinary incontinence treatment can increase physical activity and so improve the quality of life of patients, that can be measure by activity sensors.

NCT ID: NCT03997045 Recruiting - Healthy Clinical Trials

Exercise During Pregnancy and Urinary Incontinence

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to examine the effect of a supervised physical exercise program during pregnancy on urinary incontinence.

NCT ID: NCT03996070 Recruiting - Clinical trials for Female Stress Incontinence

VESPER: Stress Urinary Incontinence STUDY

VESPER-SUI
Start date: June 6, 2022
Phase: N/A
Study type: Interventional

Patients seen with stress urinary incontinence (SUI) that have failed conservative treatments will be offered to participate in a sham controlled RCT of outpatient therapy with the Fotona Smooth Erbium Yag laser. Patients will be randomised to either outpatient laser treatments or sham treatments. Patients will be blinded to which arm they have been randomised. Patients will be asked to complete appropriate relevant symptom and quality of life questionnaires prior to treatment and then at 6 and 12 months following the final treatment. At 6 months Sham patients will be un-blinded and offered the laser therapy if they wish.

NCT ID: NCT03975686 Recruiting - Clinical trials for Stress Urinary Incontinence

Effects of Neuromuscular Pelvic Realigning Exercises on Pelvic Floor Muscle Function in Continent SubjectS

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

The goal of this research study is to investigate the effect of a new neuromuscular approach for correcting pelvic alignment and improving pelvic floor muscle function. Investigators hypothesized that this approach would be significantly superior than no intervention to improve the ability of pelvic floor muscle contraction, measured by transabdominal sonography as bladder base elevation. Participants will be randomized to the intervention and control groups. while intervention group will receive five supervised sessions of pelvic realigning exercises, the control group will receive no intervention. Bladder base elevation will be measured as an indicator of pelvic floor muscle function, before and after one week intervention in both control and intervention groups.